The clinical outcomes of high neutralizing antibodies titer convalescent plasma therapy in early developed severe COVID-19 patients; a case-control study

• Principais autores: Nuttakant Nontawong (Autor), Taweegrit Siripongboonsitti (Autor), Kriangkrai Tawinprai (Autor), Mana Boonpratoom (Autor), Nawin Krailassiri (Autor), Chayaporn Boonkhum (Autor), Kamonwan Soonklang (Autor), Yong Poovorawan (Autor), Nithi Mahanonda (Autor)
• Formato: Livro
• Publicado em: BMC, 2022-11-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Background Coronavirus disease 2019 (COVID-19) causes life-threatening pneumonia. Convalescent plasma therapy (CPT) is expected to be the effective COVID-19 treatment for passive immunity. The high neutralizing antibodies titer of CPT is needed to prove the benefit in early developed severe...